Citation Impact
Citing Papers
Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997
2007
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Sequence of Testing for Monoclonal Gammopathies Serum and Urine Assays
1999
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
The Lysosomotropic Agent, Hydroxychloroquine, Delivered in a Biodegradable Nanoparticle System, Overcomes Drug Resistance of B-Chronic Lymphocytic Leukemia Cells In Vitro
2010
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells
1999
Sequence of Testing for Monoclonal Gammopathies
1999
P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications
1999
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Is P-Glycoprotein a Sufficient Marker for Multidrug Resistance in Vivo? Immunohistochemical Staining for P-Glycoprotein in Children and Adult Leukemia: Correlation with Clinical Outcome
1995
The genetics of haemochromatosis
1988
Cerebral venous thrombosis: an update
2007 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
1994
Multidrug resistance (MDR) in cancer
2000
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Prevalence of Helicobacter pylori infection in subtypes of gastric cancer
1995
Treatment of acute promyelocytic leukaemia
2001
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE
1999
Reversal of Multidrug Resistance by 7-O-Benzoylpyripyropene A in Multidrug-Resistant Tumor Cells.
2000 StandoutNobel
Acute and chronic arsenic toxicity
2003 Standout
Cremophor EL
2001 Standout
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Relation between Histologic Subtypes and Location of Gastric Cancer andHelicobacter pylori
1997
Familial multiple myeloma: report of fifteen families
1999
Evaluating treatment strategies in chronic lymphocytic leukemia
2001
Molecular mechanisms of cisplatin resistance
2011 Standout
Targeting multidrug resistance in cancer
2006 Standout
Chemotherapy and the war on cancer
2005 Standout
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Microparticles and their emerging role in cancer multidrug resistance
2011
Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
1998 Standout
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
2000
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia
1999
Monoclonal Gammopathy of Undetermined Significance
2005
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
The functions of thrombospondin-1 and-2
2000 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
The ferritins: molecular properties, iron storage function and cellular regulation
1996 Standout
Pharmacologic circumvention of multidrug resistance
1993
Clinical relevance of P-glycoprotein expression in haematological malignancies
1994
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
1997
The physician–patient relationship and quality of life: Lessons from chronic lymphocytic leukemia
2008
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
2015
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
P-glycoprotein, multidrug resistance and tumor progression
1994
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
2009
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
2002 Standout
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel.
2001
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 Standout
Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors
2002
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Cancer Cell Cycles
1996 StandoutScience
Nonviral Vectors for Gene Delivery
2008 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
2013 Standout
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study
1996
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
2004 Standout
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL
2003
Cerebral venous thrombosis
2004
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
1995
Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials
1999
Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage
1996
Works of R Leblay being referenced
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia.
1991
Chlorambucil in Indolent Chronic Lymphocytic Leukemia
1998
Gammapathie triclonale et syndrome immunoprolifératif malin
1997
Multiple myeloma in two brothers. An immunochemical and immunogenetic familial study
1986
Hypertension intracrânienne par thrombose d'un sinus latéral au cours d'une maladie de Vaquez
1985
Is the HLA‐linked haemochromatosis allele implicated in idiopathic refractory sideroblastic anaemia?
1985
Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]
1993
Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]
1993
Splenectomy for splenomegaly exceeding 1000 grams: Analysis of 47 patients
1993